<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kevin R Krull, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Eugenia Chan, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marilyn Augustyn, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 09, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Attention deficit hyperactivity disorder (ADHD) is a disorder that manifests in childhood with symptoms of hyperactivity, impulsivity, and/or inattention. The symptoms affect cognitive, academic, behavioral, emotional, and social functioning [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         below.)
        </p>
        <p>
         This topic review focuses on the clinical features and evaluation of ADHD. The epidemiology, pathogenesis, management, and prognosis of ADHD in children and adolescents and ADHD in adults are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/602.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/623.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/621.html" rel="external">
          "Pharmacology of drugs used to treat attention deficit hyperactivity disorder in children and adolescents"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16927.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5763.html" rel="external">
          "Cardiac evaluation of patients receiving pharmacotherapy for attention deficit hyperactivity disorder"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1232.html" rel="external">
          "Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H830607547">
         <span class="h1">
          CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h2">
          Core symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         ADHD is a syndrome with two categories of core symptoms: hyperactivity/impulsivity and inattention. Each of the core symptoms of ADHD has its own pattern and course of development. The complaint regarding symptoms of ADHD may originate from the parents, teachers, or other caregivers [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h3">
          Hyperactivity and impulsivity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperactive and impulsive behaviors almost always occur together in young children. The predominantly hyperactive-impulsive subtype of ADHD is characterized by the inability to sit still or inhibit behavior.
        </p>
        <p>
         Symptoms of hyperactivity and impulsivity may include [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Excessive fidgetiness (eg, tapping the hands or feet, squirming in seat)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Difficulty remaining seated when sitting is required (eg, at school, work, etc)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Feelings of restlessness (in adolescents) or inappropriate running around or climbing in younger children
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Difficulty playing quietly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Difficult to keep up with, seeming to always be "on the go"
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Excessive talking
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Difficulty waiting turns
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blurting out answers too quickly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Interruption or intrusion of others
        </p>
        <p>
        </p>
        <p>
         Hyperactive and impulsive symptoms typically are observed by the time the child reaches four years of age and increase during the next three to four years, peaking in severity when the child is seven to eight years of age [
         <a href="#rid3">
          3,4
         </a>
         ]. After seven to eight years of age, hyperactive symptoms begin to decline; by the adolescent years, they may be barely discernible to observers, although the adolescent may continue to feel restless or unable to settle down [
         <a href="#rid5">
          5
         </a>
         ]. In contrast, impulsive symptoms usually persist throughout life. Symptoms of impulsivity in adolescents include substance use, risky sexual behavior, and impaired driving [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/623.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Prognosis'
         </a>
         .)
        </p>
        <p>
         The focus of impulsivity is related to the environment. As an example, adolescents with ADHD who are untreated and in an environment where alcohol and other commonly abused substances are readily available are at greater risk of engaging in drug use or experimentation than are adolescents without ADHD [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Inattention
         </span>
         <span class="headingEndMark">
          —
         </span>
         The predominantly inattentive presentation of ADHD is characterized by reduced ability to focus attention and reduced speed of cognitive processing and responding [
         <a href="#rid8">
          8,9
         </a>
         ]. Children with the inattentive subtype often are described as having a sluggish cognitive tempo and frequently appear to be daydreaming or "off task" [
         <a href="#rid10">
          10
         </a>
         ]. The typical presenting complaints center on cognitive and/or academic problems. Among children born at &lt;32 weeks gestational age, symptoms of inattention appear to be more prominent than hyperactivity and impulsivity [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4967.html" rel="external">
          "Long-term neurodevelopmental impairment in infants born preterm: Epidemiology and risk factors", section on 'Risk of NDI by gestational age'
         </a>
         .)
        </p>
        <p>
         Symptoms of inattention may include [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failure to provide close attention to detail, careless mistakes
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Difficulty maintaining attention in play, school, or home activities
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seems not to listen, even when directly addressed
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fails to follow through (eg, homework, chores, etc)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Difficulty organizing tasks, activities, and belongings
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Avoids tasks that require consistent mental effort
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Loses objects required for tasks or activities (eg, school books, sports equipment, etc)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Easily distracted by irrelevant stimuli
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Forgetfulness in routine activities (eg, homework, chores, morning routines, etc)
        </p>
        <p>
        </p>
        <p>
         The symptoms of inattention typically are not apparent until the child is eight to nine years of age [
         <a href="#rid3">
          3,4
         </a>
         ]. This delay may relate to reduced sensitivity of assessment of attention problems or increased variability in the normal development of the cognitive skills. Similar to the pattern of impulsivity, symptoms of inattention usually are a lifelong problem [
         <a href="#rid12">
          12
         </a>
         ]. In adolescents, symptoms of inattention may result in academic difficulty [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/623.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Prognosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15721103">
         <span class="h2">
          Impaired functioning
         </span>
         <span class="headingEndMark">
          —
         </span>
         To meet criteria for ADHD, core symptoms must impair function in academic, social, or occupational activities [
         <a href="#rid1">
          1
         </a>
         ]. Social skills in children with ADHD often are significantly impaired. Problems with inattention may limit opportunities to acquire social skills or to attend to social cues necessary for effective social interaction, making it difficult to form friendships. Hyperactive and impulsive behaviors may result in peer rejection [
         <a href="#rid13">
          13
         </a>
         ]. The negative consequences of impaired social function (eg, poor self-esteem, increased risk for depression and anxiety) may be long standing.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Indications and process
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evaluation for ADHD should be initiated in children ≥4 years of age who have symptoms of inattention, hyperactivity, or impulsivity or who have complaints frequently associated with ADHD (eg, poor school performance, difficulty making and keeping friends, difficulty with team sports) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         The evaluation for possible ADHD includes comprehensive medical, developmental, educational, and psychosocial evaluation [
         <a href="#rid2">
          2,6,14-19
         </a>
         ].
        </p>
        <p>
         Comprehensive evaluation is necessary to confirm the presence, persistence, pervasiveness, and functional complications of core symptoms, exclude other explanations for core symptoms  (
         <a class="graphic graphic_table graphicRef69771" href="/z/d/graphic/69771.html" rel="external">
          table 1
         </a>
         ), and identify coexisting emotional, neurodevelopmental, behavioral, and medical disorders. (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         below and
         <a class="local">
          'Differential diagnosis'
         </a>
         below and
         <a class="local">
          'Evaluation for coexisting disorders'
         </a>
         below.)
        </p>
        <p>
         The evaluation should include review of the medical, social, and family histories; clinical interviews with the caregiver and patient; review of information about functioning in school or day care; and evaluation for coexisting emotional, neurodevelopmental, or behavioral disorders [
         <a href="#rid6">
          6,14-17,19
         </a>
         ]. The necessary information may be obtained in several ways, including in-person discussions, questionnaires, and web-based tools, as described in the sections below.
        </p>
        <p>
         The complete evaluation may require several office visits [
         <a href="#rid14">
          14
         </a>
         ]. It is important to discuss safety and injury prevention at each visit because children with ADHD or symptoms of ADHD are at increased risk of intentional and unintentional injury compared with children without these symptoms. (See
         <a class="medical medical_review" href="/z/d/html/623.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Prognosis'
         </a>
         .)
        </p>
        <p>
         Reevaluation of children with ADHD is warranted whenever symptoms worsen or new symptoms emerge because the differential diagnosis of ADHD is extensive and comorbidity is common. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below and
         <a class="local">
          'Evaluation for coexisting disorders'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Medical evaluation
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          History
         </strong>
         – Important aspects of the medical history include prenatal exposures (eg, tobacco, drugs, alcohol), perinatal complications or infections, central nervous system infection, head trauma, recurrent otitis media, and medications [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Family history of similar behaviors is important because ADHD has a strong genetic component. (See
         <a class="medical medical_review" href="/z/d/html/602.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis", section on 'Genetic factors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The review of systems should include information about sleep disturbances [
         <a href="#rid6">
          6,20
         </a>
         ]. It is particularly important to obtain a dietary history (eg, appetite, picky eating) and history of sleep patterns before initiation of pharmacotherapy to avoid attributing preexisting problems to medications [
         <a href="#rid6">
          6
         </a>
         ]. It is also important to obtain a thorough child and family cardiac history and cardiac review of systems before initiating medications. (See
         <a class="medical medical_review" href="/z/d/html/97875.html" rel="external">
          "Sleep in children and adolescents with attention deficit hyperactivity disorder"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5763.html" rel="external">
          "Cardiac evaluation of patients receiving pharmacotherapy for attention deficit hyperactivity disorder", section on 'Pretreatment clinical evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The psychosocial history should include questions about environmental exposures (eg, lead, tobacco smoke), family stress, problematic relationships, and adverse childhood experiences (ACEs), which can affect the child's general functioning [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         To elicit concerns regarding school performance and behavior, the pediatric care provider can ask [
         <a href="#rid21">
          21
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         How the child is doing at school
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Whether the caregiver or the teacher has noticed any problems with learning
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Whether the child is happy in school
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Whether the child has any behavioral problems at school or home, or when playing with friends
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Whether the child has problems completing school assignments at school or home
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physical examination
         </strong>
         – The physical examination of most children with ADHD is normal. However, the examination is necessary to evaluate other possibilities in the differential diagnosis. Important aspects of the examination include [
         <a href="#rid6">
          6,14,21
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Measurement of height, weight, head circumference, and vital signs
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Assessment of dysmorphic features and neurocutaneous abnormalities (eg, characteristic features of fetal alcohol syndrome  (
         <a class="graphic graphic_picture graphicRef94607" href="/z/d/graphic/94607.html" rel="external">
          picture 1
         </a>
         ) or fragile X syndrome  (
         <a class="graphic graphic_picture graphicRef60035" href="/z/d/graphic/60035.html" rel="external">
          picture 2
         </a>
         ))
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A complete neurologic examination, including assessment of vision and hearing, assessment of coordination, observation for verbal or motor tics
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Observation of the child's behavior in the office setting; however, this isolated assessment of behavior should be interpreted cautiously; symptoms of ADHD may not be apparent in the structured setting of the clinic visit, or nervousness/apprehension could be misinterpreted as symptoms of ADHD
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Observation of the child's communication skills, particularly nonverbal and pragmatic communication (ie, ability to successfully use language in context), which are impaired in children with autism spectrum disorder (ASD), an important consideration in the differential diagnosis (see
         <a class="medical medical_review" href="/z/d/html/627.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Clinical features", section on 'Nonverbal and pragmatic communication behaviors'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Developmental and behavioral evaluation
         </span>
        </p>
        <p class="headingAnchor" id="H964243024">
         <span class="h3">
          Behavior assessment and history
         </span>
         <span class="headingEndMark">
          —
         </span>
         Important aspects of the developmental and behavioral history include [
         <a href="#rid14">
          14
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Specific information about the onset, course, and functional impact of ADHD symptoms
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Emotional, medical, and developmental events that may provide an alternative explanation for the symptoms (see
         <a class="local">
          'Differential diagnosis'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Developmental milestones, particularly language milestones  (
         <a class="graphic graphic_table graphicRef58598" href="/z/d/graphic/58598.html" rel="external">
          table 2
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         School absences
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Psychosocial stressors, including any ACEs such as food insecurity, homelessness, neglect, community violence [
         <a href="#rid22">
          22,23
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Observation of caregiver-child interactions
        </p>
        <p>
        </p>
        <p>
         The behavioral assessment is focused on determining the age of onset of the core symptoms of ADHD, the duration of symptoms, the settings in which the symptoms occur, and the degree of functional impairment [
         <a href="#rid2">
          2,14,15
         </a>
         ]. This information is necessary to establish the diagnosis of ADHD. (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         below.)
        </p>
        <p>
         Information about the core symptoms can be obtained through the use of open-ended questions or from ADHD-specific rating scales. If open-ended questions are used, the examiner must document the presence of the relevant behaviors from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H189248586">
         <span class="h3">
          Behavior rating scales
         </span>
         <span class="headingEndMark">
          —
         </span>
         Various scales have been developed to collect structured observations of behavior  (
         <a class="graphic graphic_table graphicRef81675" href="/z/d/graphic/81675.html" rel="external">
          table 3
         </a>
         ). Completion of these scales by parents or caregivers and teachers during the diagnostic evaluation helps to establish the presence of core symptoms of ADHD in more than one setting. Although the rating scales may identify symptoms of ADHD, rating scales do not determine whether the symptoms are due to ADHD and are subject to the interpretation of the rater (who may misunderstand the behaviors), and rating scales may not provide information about contextual influences (eg, what happened before the behaviors occurred) [
         <a href="#rid6">
          6
         </a>
         ]. Rating scales derived from ADHD criteria in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) can be used if rating scales derived from DSM-5 criteria are not available because the core symptoms of ADHD in DSM-IV and DSM-5 are virtually identical [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          ADHD-specific scales
         </strong>
         – ADHD-specific rating scales (also called narrow-band scales) focus directly on the symptoms of ADHD and can be used to establish the presence of the core symptoms of ADHD. The validity of ADHD rating scales in distinguishing children with ADHD from age-matched control children varies depending upon the age of the child, the scale that is used, and the informant (eg, parent or caregiver, teacher, adolescent) [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         ADHD-specific rating scales have a sensitivity and specificity of greater than 90 percent when used in an appropriate population [
         <a href="#rid24">
          24,25
         </a>
         ]. However, most of the studies validating the use of rating scales have taken place in referral rather than primary care settings. The first edition of the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nichq.org%2Fresource%2Fcaring-children-adhd-resource-toolkit-clinicians&amp;token=zdFETL7sY7KzqjhZf9oR42LowCTa16H4ROpKLhTFdh8YlI5LYkc%2BGXGbQNzXACOaOYk%2Bjg9k41lGDpmUKjbF4tT%2FU7XNDOWPmVdn3H3Rjig%3D&amp;TOPIC_ID=624" target="_blank">
          National Institute for Children's Healthcare Quality (NICHQ) ADHD toolkit
         </a>
         includes the Vanderbilt Assessment Scales, which can be downloaded and printed from the website. The Vanderbilt Assessment Scales have been validated in both community and referral settings using longitudinal assessment and follow-up [
         <a href="#rid26">
          26-28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Only the Conners Comprehensive Behavior Rating Scales and the ADHD Rating Scale IV have been validated in preschool-aged children (ie, age four through five years) [
         <a href="#rid2">
          2,29
         </a>
         ]. The ADHD Rating Scale-5 has been validated in children age 5 through 17 years [
         <a href="#rid30">
          30
         </a>
         ]. The Vanderbilt rating scales were not designed for preschool children but can be used in children ≥4 years because the DSM-5/DSM 5-TR behavioral criteria for ADHD are the same for children age 4 through 17 years [
         <a href="#rid1">
          1,2,31-33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Broadband scales
         </strong>
         – Broadband scales assess a variety of behavioral symptoms, including, but not limited to, the core symptoms of ADHD; they assess internalizing behaviors (eg, feeling depressed, anxious, withdrawn) and externalizing behaviors other than ADHD (eg, aggression). Broadband scales (with the exception of the Conners' Long form) are not recommended to establish the presence of the core symptoms of ADHD because they are less sensitive and specific (&lt;86 percent) than ADHD-specific scales [
         <a href="#rid25">
          25
         </a>
         ]. However, broadband scales can help to identify coexisting conditions and narrow the differential diagnosis [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/615.html" rel="external">
          "Developmental-behavioral surveillance and screening in primary care", section on 'Choice of screening test'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Educational evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The educational assessment centers on documentation of the core symptoms in the educational setting. Important aspects of the educational evaluation include [
         <a href="#rid2">
          2,6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Completion of an ADHD-specific rating scale (see
         <a class="local">
          'Behavior rating scales'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A narrative summary of classroom behavior and interventions, learning patterns, and functional impairment
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Copies of report cards and samples of schoolwork
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Review of school-based multidisciplinary evaluations (if such evaluations have been performed)
        </p>
        <p>
        </p>
        <p>
         The teachers who provide the information should have regular contact with the child for a minimum of four to six months if they are to comment reliably on the persistence of symptoms. In the United States, public schools are federally mandated to perform appropriate evaluations (eg, language, cognitive) at no cost to the family if a child is suspected of having a disability that impairs functioning (eg, ADHD or learning disorder). (See
         <a class="medical medical_review" href="/z/d/html/626.html" rel="external">
          "Definitions of specific learning disorder and laws pertaining to learning disorders in the United States", section on 'Laws affecting the education of students with disabilities'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2840.html" rel="external">
          "Children and youth with special health care needs", section on 'School-based services'
         </a>
         .)
        </p>
        <p>
         Obtaining information about the core symptoms of ADHD from professionals in after-school programs or other structured settings also may be helpful [
         <a href="#rid2">
          2,6
         </a>
         ]. This information may be particularly useful in the evaluation of preschool children and adolescents, or if discrepancies exist between the caregivers' and teachers' reports of core symptoms. When such discrepancies occur, environmental factors (eg, different expectations, levels of structure, or behavior management strategies) may be contributing to the symptoms. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Evaluation for coexisting disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation for ADHD should include assessment for coexisting developmental, cognitive, physical, and behavioral/emotional disorders because coexisting disorders are common among children with ADHD, require treatment in conjunction with ADHD, and may affect the treatment for ADHD [
         <a href="#rid2">
          2,35-41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/623.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Treatment of coexisting conditions'
         </a>
         .)
        </p>
        <p>
         Urgent evaluation is necessary for children with suicidal ideation or the potential to harm themselves or others (eg, children with severe outbursts of anger) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         Common coexisting disorders are listed below. The evaluation for most of these disorders is discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Learning disorders (see
         <a class="medical medical_review" href="/z/d/html/613.html" rel="external">
          "Specific learning disorders in children: Evaluation"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Language disorder (see
         <a class="medical medical_review" href="/z/d/html/619.html" rel="external">
          "Evaluation and treatment of speech and language disorders in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         ASD (see
         <a class="medical medical_review" href="/z/d/html/628.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Evaluation and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Developmental coordination disorder (see
         <a class="medical medical_review" href="/z/d/html/594.html" rel="external">
          "Developmental coordination disorder: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sleep disorders (see
         <a class="medical medical_review" href="/z/d/html/6357.html" rel="external">
          "Assessment of sleep disorders in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tics (see
         <a class="medical medical_review" href="/z/d/html/6232.html" rel="external">
          "Hyperkinetic movement disorders in children", section on 'Tic disorders'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6221.html" rel="external">
          "Tourette syndrome: Pathogenesis, clinical features, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depression and suicidality (see
         <a class="medical medical_review" href="/z/d/html/1224.html" rel="external">
          "Pediatric unipolar depression: Epidemiology, clinical features, assessment, and diagnosis", section on 'Epidemiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1229.html" rel="external">
          "Suicidal behavior in children and adolescents: Epidemiology and risk factors", section on 'Psychiatric disorder'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anxiety (see
         <a class="medical medical_review" href="/z/d/html/15926.html" rel="external">
          "Anxiety disorders in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, and course"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/93408.html" rel="external">
          "Anxiety disorders in children and adolescents: Assessment and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Substance use (see
         <a class="medical medical_review" href="/z/d/html/16927.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications", section on 'Prerequisites'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101699.html" rel="external">
          "Substance use disorder in adolescents: Epidemiology, clinical features, assessment, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oppositional defiant disorder – Oppositional defiant disorder (ODD) is characterized by a persistent pattern of angry or irritable mood, argumentative or defiant behavior, and vindictiveness that is associated with distress in the patient or close contacts or impairs ability to function in social, school, work, or other settings [
         <a href="#rid42">
          42
         </a>
         ]. Broadband behavior scales can be used as a preliminary screen for ODD. (See
         <a class="medical medical_review" href="/z/d/html/121430.html" rel="external">
          "Oppositional defiant disorder: Epidemiology, clinical manifestations, course, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Conduct disorder
         <strong>
         </strong>
         –
         <strong>
         </strong>
         Conduct disorder is characterized by a persistent pattern of aggression toward people or animals, destruction of property, deceitfulness or theft, and serious violation of rules that affects ability to function in social, school, or work settings [
         <a href="#rid43">
          43
         </a>
         ]. Broadband behavior scales can be used as a preliminary screen for conduct disorder.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h2">
          Ancillary evaluation for select patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other evaluations are not routinely indicated to establish the diagnosis of ADHD but may be warranted to evaluate comorbid conditions or conditions remaining in the differential diagnosis after the initial assessment. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.) These evaluations may include [
         <a href="#rid6">
          6,14,15,44
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Speech and language evaluation (language or communication disorder) (see
         <a class="medical medical_review" href="/z/d/html/619.html" rel="external">
          "Evaluation and treatment of speech and language disorders in children", section on 'Speech and language evaluation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Occupational therapy evaluation (motor coordination disorder) (see
         <a class="medical medical_review" href="/z/d/html/594.html" rel="external">
          "Developmental coordination disorder: Clinical features and diagnosis", section on 'Clinical features'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mental health evaluation (mood disorder, anxiety, oppositional defiant disorder, conduct disorder, obsessive-compulsive disorder, posttraumatic stress disorder, adjustment disorder) (see
         <a class="local">
          'Evaluation for coexisting disorders'
         </a>
         above and
         <a class="local">
          'Indications for referral'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood lead level (lead poisoning) [
         <a href="#rid45">
          45,46
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/6491.html" rel="external">
          "Childhood lead poisoning: Clinical manifestations and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thyroid hormone levels (thyroid disorder) [
         <a href="#rid47">
          47
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/5841.html" rel="external">
          "Clinical manifestations and diagnosis of Graves disease in children and adolescents", section on 'Diagnostic evaluation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Genetic testing and/or genetics consultation (fragile X syndrome) [
         <a href="#rid48">
          48,49
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/2924.html" rel="external">
          "Fragile X syndrome: Clinical features and diagnosis in children and adolescents", section on 'Diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Overnight polysomnography for children with symptoms suggestive of and/or risk factors for obstructive sleep apnea syndrome, restless legs syndrome, or circadian rhythm disorder (see
         <a class="medical medical_review" href="/z/d/html/6363.html" rel="external">
          "Evaluation of suspected obstructive sleep apnea in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16995.html" rel="external">
          "Restless legs syndrome and periodic limb movement disorder in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neurology consultation or EEG (electroencephalography; neurologic or seizure disorder) (see
         <a class="medical medical_review" href="/z/d/html/6218.html" rel="external">
          "Seizures and epilepsy in children: Clinical and laboratory diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psychological or neuropsychological testing
         </strong>
         – Psychological testing (ie, cognitive and academic testing) is not necessary in the routine evaluation for ADHD and does not distinguish children with ADHD from those without ADHD [
         <a href="#rid15">
          15,50,51
         </a>
         ]. It is, however, recommended in the evaluation for complex ADHD [
         <a href="#rid41">
          41
         </a>
         ]. Psychological testing can help to exclude other disorders (eg, learning disorder) or to identify specific problem areas for children with ADHD, including abstract reasoning, mental flexibility, planning, and working memory, a collection of skills broadly categorized as "executive functions" [
         <a href="#rid8">
          8,9,52,53
         </a>
         ]. Neuropsychologic assessment of these skills, as well as direct assessment of attention and behavioral disinhibition, often is desirable to facilitate diagnosis, plan environmental and behavioral interventions, and track progress of treatment [
         <a href="#rid54">
          54-57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The public school system often is the best place to obtain basic psychometric testing, though more specialized neuropsychologic testing requires consultation with a specialist. Testing for learning disorders can be completed in whole or in part by the school system. (See
         <a class="medical medical_review" href="/z/d/html/15399.html" rel="external">
          "Specific learning disorders in children: Role of the primary care provider", section on 'Requesting evaluation in the school district'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3305562690">
         <span class="h2">
          Tests not routinely recommended
         </span>
        </p>
        <p class="headingAnchor" id="H3232720328">
         <span class="h3">
          Quantitative EEG
         </span>
         <span class="headingEndMark">
          —
         </span>
         Quantitative electroencephalography (qEEG) is a method of analyzing the electrical activity of the brain to derive quantitative patterns that may correspond to diagnostic information and/or cognitive deficits [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         We do not suggest qEEG for the evaluation of children with ADHD. Although the US Food and Drug Administration has licensed the first EEG test for assessment of children (6 to 17 years of age) for ADHD [
         <a href="#rid59">
          59
         </a>
         ] and several studies have demonstrated differences in qEEG between children with ADHD and normal children [
         <a href="#rid60">
          60-65
         </a>
         ], the studies were limited by nonrandom assignment, lack of blinding, failure to consider comorbidities, and/or failure to control for pharmacologic therapy [
         <a href="#rid58">
          58,63,66
         </a>
         ]. In addition, the EEG patterns differ in males and females [
         <a href="#rid67">
          67
         </a>
         ]. A 2013 meta-analysis of nine studies (including 1253 children with ADHD and 517 without ADHD) found significant heterogeneity and concluded that EEG profiles (specifically an increased theta to beta ratio) cannot be used to reliably diagnose ADHD (although they may be helpful for prognosis) [
         <a href="#rid68">
          68
         </a>
         ]. Evidence is insufficient to support the use of qEEG over clinical evaluation of symptoms and functional impairment for the diagnosis of ADHD [
         <a href="#rid18">
          18,69
         </a>
         ]. (See
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H830607507">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H830607650">
         <span class="h2">
          Diagnostic criteria
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DSM-5-TR
         </strong>
         – The American Psychiatric Association has defined consensus criteria for the diagnosis of ADHD, which are published in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) [
         <a href="#rid1">
          1
         </a>
         ]. For children &lt;17 years, the DSM-5-TR diagnosis of ADHD requires ≥6 symptoms of hyperactivity and impulsivity or ≥6 symptoms of inattention. For adolescents ≥17 years and adults, ≥5 symptoms of hyperactivity and impulsivity or ≥5 symptoms of inattention are required. (See
         <a class="local">
          'Hyperactivity and impulsivity'
         </a>
         above and
         <a class="local">
          'Inattention'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The symptoms of hyperactivity/impulsivity or inattention must [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Occur often
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Be present in more than one setting (eg, school and home)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persist for at least six months
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Be present before the age of 12 years
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Impair function in academic, social, or occupational activities
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Be excessive for the developmental level of the child
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, other physical, situational, or mental health conditions that could account for the symptoms must be excluded. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Adherence to the DSM-5-TR criteria can help to minimize over- and under-diagnosis of ADHD. The diagnostic criteria have high interrater reliability for individual items and for overall diagnosis even though the behavioral characteristics specified in the definition are subject to different interpretation by different observers [
         <a href="#rid70">
          70,71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Limitations of the DSM-5-TR criteria include their derivation from studies of children who were evaluated in psychiatric rather than primary care settings and lack of data supporting the number of items required for diagnosis. In addition, the criterion that symptoms of hyperactivity/impulsivity or inattention be present before the age of 12 years is controversial. (See
         <a class="medical medical_review" href="/z/d/html/1232.html" rel="external">
          "Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis", section on 'Course'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Positive or negative response to stimulant medication cannot be used to confirm or refute the diagnosis of ADHD [
         <a href="#rid70">
          70
         </a>
         ]. Stimulant medications improve behavior in children with ADHD, children with conditions other than ADHD (eg, learning disorders, depression), and normal control children [
         <a href="#rid72">
          72,73
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          ICD-11 –
         </strong>
         In other countries, the ADHD is defined by the International Classification of Diseases (11
         <sup>
          th
         </sup>
         edition, ICD-11) criteria for ADHD  (
         <a class="graphic graphic_table graphicRef53723" href="/z/d/graphic/53723.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid74">
          74
         </a>
         ]. In the 10
         <sup>
          th
         </sup>
         edition, ADHD was called hyperkinetic disorder.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H89958659">
         <span class="h2">
          ADHD presentations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depending upon the predominant symptoms, ADHD can be categorized into one of the three presentations listed below [
         <a href="#rid1">
          1,74
         </a>
         ]. The presentation of ADHD in a given patient can change from one to another over time [
         <a href="#rid1">
          1,75-77
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Predominantly inattentive
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         DSM-5-TR criteria require ≥6 symptoms of inattention for children &lt;17 years; ≥5 symptoms for adolescents ≥17 years and adults
         <strong>
          and
         </strong>
         &lt;6 symptoms of hyperactivity-impulsivity [
         <a href="#rid1">
          1
         </a>
         ] (see
         <a class="local">
          'Inattention'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ICD-11 specifies that all diagnostic requirements for ADHD are met and inattentive symptoms predominate
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Predominantly hyperactive-impulsive
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         DSM-5-TR criteria require ≥6 symptoms of hyperactivity-impulsivity for children &lt;17 years; ≥5 symptoms for adolescents ≥17 years and adults
         <strong>
          and
         </strong>
         &lt;6 symptoms of inattention [
         <a href="#rid1">
          1
         </a>
         ] (see
         <a class="local">
          'Hyperactivity and impulsivity'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ICD-11 specifies that all diagnostic requirements for ADHD are met and hyperactive/impulsive symptoms predominate
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Combined
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         DSM-5-TR criteria require ≥6 symptoms of inattention and ≥6 symptoms of hyperactivity-impulsivity for children &lt;17 years; ≥5 symptoms in each category for adolescents ≥17 years and adults [
         <a href="#rid1">
          1
         </a>
         ] (see
         <a class="local">
          'Inattention'
         </a>
         above and
         <a class="local">
          'Hyperactivity and impulsivity'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ICD-11 specifies that all diagnostic requirement for ADHD are met and neither inattentive nor hyperactive/impulsive symptoms clearly predominate
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H830607531">
         <span class="h2">
          Diagnosis in preschool children
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnostic criteria for ADHD (without subtyping) can be applied to children as young as four years of age [
         <a href="#rid2">
          2,78
         </a>
         ]. Longitudinal studies suggest that severe hyperactivity, which is present in only a small subset of preschool children, persists into the school years [
         <a href="#rid79">
          79-82
         </a>
         ].
        </p>
        <p>
         The criterion that impairment is present in at least two settings may be difficult to meet if the child does not attend preschool or a child care program [
         <a href="#rid2">
          2
         </a>
         ]. In such circumstances, clinicians who suspect ADHD can recommend that the caregivers attend a parent/caregiver training program or that the child be enrolled in a qualified preschool program (eg, Head Start, public prekindergarten programs, Early Childhood Special Education services) [
         <a href="#rid2">
          2,51
         </a>
         ]. The clinician can then obtain information about core symptoms of ADHD and functional impairment from the instructors of the preschool program or the parenting program (if the child is directly observed).
        </p>
        <p>
         If caregiver and teacher ratings are discordant, differing expectations and environmental factors should be considered (eg, structure, rules, adult authority) [
         <a href="#rid6">
          6,83
         </a>
         ]. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H830607539">
         <span class="h2">
          Diagnosis in adolescents
         </span>
         <span class="headingEndMark">
          —
         </span>
         Establishing a new diagnosis of ADHD in adolescents can be challenging. Adolescents may underreport core symptoms or functional impairment and may spend too little time at home for caregivers to be accurate informants [
         <a href="#rid2">
          2,5,84
         </a>
         ]. In such cases, it is important for clinicians to obtain information from at least two teachers and/or other adults with whom the adolescent interacts (eg, guidance counselor, tutor, coach, etc) [
         <a href="#rid2">
          2
         </a>
         ]. Strict adherence to the criterion that symptoms of hyperactivity/impulsivity or inattention be present before the age of 12 years may fail to identify adolescents and adults with more subtle attentional or organizational problems or adolescents who have above average cognitive abilities. (See
         <a class="medical medical_review" href="/z/d/html/1232.html" rel="external">
          "Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         Adolescents being evaluated for ADHD should be interviewed privately [
         <a href="#rid6">
          6
         </a>
         ]. Although adolescent patients may not accurately report their symptoms or strengths and weaknesses [
         <a href="#rid85">
          85
         </a>
         ], they may provide other important information unknown to or undisclosed by caregivers or teachers (eg, symptoms of depression or anxiety, risky behaviors, substance use or misuse of prescription drugs, bullying, information about the home environment) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         When considering a diagnosis of "late onset" ADHD in adolescents and young adults, it is particularly important to obtain a psychiatric history and assessment of current functioning, ideally from multiple sources. In long-term follow-up of a randomized trial, 239 individuals without childhood ADHD underwent at least two comprehensive assessments for ADHD between baseline (mean age 10 years) and young adulthood (mean age 24 years) [
         <a href="#rid86">
          86
         </a>
         ]. Although 143 screened positive on symptom checklists in adolescence or young adulthood, late-onset ADHD was excluded in approximately 95 percent by lack of clinical impairment, lack of cross-situational confirmation (eg, parents/caregivers, teachers, other informants), or an alternative explanation for symptoms (eg, substance use, another mental illness).
        </p>
        <p>
         Another possible explanation for new onset of ADHD symptoms in adolescents is frequent digital media use (eg, checking social media, playing games alone, video chatting). In a longitudinal cohort of 2587 15- and 16-year-olds who did not have self-reported symptoms of ADHD at baseline, self-reported higher-frequency digital media use was associated with self-reported ADHD symptoms over two years of follow-up [
         <a href="#rid87">
          87
         </a>
         ]. The frequent distraction and rapid feedback of digital media may disrupt normal development of sustained attention, impulse control, and ability to delay gratification. In addition, digital media may displace other activities that build attention span and executive function [
         <a href="#rid87">
          87,88
         </a>
         ]. It remains to be determined whether symptoms that develop in response to media use require or respond to typical ADHD treatments.
        </p>
        <p>
         Finally, it is important to consider the possibility that adolescent patients may intentionally misreport or misrepresent their symptoms for various reasons (eg, to obtain medications, school accommodations, or accommodations for standardized testing) [
         <a href="#rid6">
          6,89
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H341279665">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The symptoms of ADHD overlap with a number of other conditions, including developmental variations, neurologic or developmental conditions, emotional and behavioral disorders, psychosocial or environmental factors, and certain medical problems  (
         <a class="graphic graphic_table graphicRef69771" href="/z/d/graphic/69771.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1,2,90-92
         </a>
         ]. Some of these conditions coexist with ADHD and may or may not be responsible for some of the symptoms (eg, children who have learning disorders may exhibit inattention as a result of difficulties learning new information) [
         <a href="#rid93">
          93
         </a>
         ]. These conditions usually can be differentiated from ADHD with a thorough history and/or the use of a broadband behavior rating scale. If the diagnosis remains uncertain, psychological testing or a mental health evaluation may be necessary. (See
         <a class="local">
          'Evaluation for coexisting disorders'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Developmental variations
         </strong>
         – Developmental variations include intellectual disability, giftedness, and behaviors that are within the normal range for the child's level of development and do not impair function (eg, a short attention span or increased motor activity in a preschool child; occasional impulsivity in a school-age child) [
         <a href="#rid90">
          90,91
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6172.html" rel="external">
          "Intellectual disability (ID) in children: Clinical features, evaluation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6189.html" rel="external">
          "Intellectual disability in children: Evaluation for a cause"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When considering behaviors that are within the normal range for the child's level of development, relative age and maturity within a specific grade are more important than the grade level itself [
         <a href="#rid94">
          94,95
         </a>
         ]. In observational studies, younger age for a particular grade level has been associated with increased diagnosis of and treatment for ADHD in children [
         <a href="#rid96">
          96-99
         </a>
         ], suggesting that developmental immaturity may account for some behaviors that are attributed to ADHD and highlighting the importance of adhering to ADHD diagnostic criteria for diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Children with developmental variations do not meet the full criteria for ADHD. (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neurologic or developmental conditions
         </strong>
         – Neurodevelopmental conditions that can mimic or co-occur with ADHD are listed below [
         <a href="#rid90">
          90,100,101
         </a>
         ]. These disorders usually can be distinguished from ADHD through history and examination. Specialized testing may be necessary in some circumstances.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Learning disorders or language/communication disorders (see
         <a class="medical medical_review" href="/z/d/html/610.html" rel="external">
          "Specific learning disorders in children: Clinical features"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/616.html" rel="external">
          "Etiology of speech and language disorders in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Children with learning, language, visual-motor, or auditory processing problems can be difficult to distinguish from those with ADHD. Similar to ADHD, these problems tend to be pervasive and persistent and can impair academic function. Children with these problems may attempt to avoid tasks through inattention, getting out of their seats, or impulsively guessing at answers. Similar to children with these problems, children with ADHD may perform poorly on language and visual-spatial tasks [
         <a href="#rid52">
          52,102,103
         </a>
         ], particularly those that require sustained mental effort or are sensitive to impulsive responding (eg, multiple-choice formats).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Comprehensive neuropsychological testing may help to clarify the diagnosis. Children with learning, language, visual-motor, or auditory processing problems usually perform poorly only in their particular problem area, whereas children with ADHD may perform poorly in several areas. (See
         <a class="medical medical_review" href="/z/d/html/613.html" rel="external">
          "Specific learning disorders in children: Evaluation", section on 'Comprehensive evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Assessment of verbal and nonverbal/performance skills with an intelligence measure such as the Wechsler Intelligence Scale for Children – Fifth Edition [
         <a href="#rid104">
          104
         </a>
         ] or the Differential Abilities Scale-II [
         <a href="#rid105">
          105
         </a>
         ] will help to identify language and/or visual-spatial processing deficits, as well as learning disorders.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Assessment of academic skills/achievement testing with a tool such as the Wechsler Individual Achievement Test – Fourth Edition [
         <a href="#rid106">
          106
         </a>
         ] or the Wide Range Achievement Test – Fifth Edition [
         <a href="#rid107">
          107
         </a>
         ] will help to identify potential learning disorders.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Autism spectrum disorders (ASD); it is particularly important to consider ASD in preschool children with symptoms of ADHD [
         <a href="#rid101">
          101
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/627.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Clinical features"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neurodevelopmental syndromes, for example:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Fragile X syndrome (see
         <a class="medical medical_review" href="/z/d/html/2924.html" rel="external">
          "Fragile X syndrome: Clinical features and diagnosis in children and adolescents"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Fetal alcohol syndrome (see
         <a class="medical medical_review" href="/z/d/html/14381.html" rel="external">
          "Fetal alcohol spectrum disorder: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Klinefelter syndrome (see
         <a class="medical medical_review" href="/z/d/html/13921.html" rel="external">
          "Clinical features, diagnosis, and management of Klinefelter syndrome"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Childhood cerebral adrenoleukodystrophy (ALD) (see
         <a class="medical medical_review" href="/z/d/html/6200.html" rel="external">
          "Clinical features, evaluation, and diagnosis of X-linked adrenoleukodystrophy", section on 'Leukodystrophy'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Genetic testing may be necessary to distinguish fragile X syndrome, Klinefelter syndrome, or childhood cerebral ALD from ADHD.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Seizure disorder; electroencephalography may be necessary to distinguish a seizure disorder from ADHD (see
         <a class="medical medical_review" href="/z/d/html/6199.html" rel="external">
          "Seizures and epilepsy in children: Classification, etiology, and clinical features"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sequelae of central nervous system infection or trauma (see
         <a class="medical medical_review" href="/z/d/html/6000.html" rel="external">
          "Bacterial meningitis in children: Neurologic complications", section on 'Intellectual and behavioral disabilities'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Metabolic disorders (eg, adrenoleukodystrophy, mucopolysaccharidosis type III) (see
         <a class="medical medical_review" href="/z/d/html/6200.html" rel="external">
          "Clinical features, evaluation, and diagnosis of X-linked adrenoleukodystrophy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2931.html" rel="external">
          "Mucopolysaccharidoses: Clinical features and diagnosis", section on 'MPS type III (Sanfilippo syndrome)'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Motor coordination disorders (eg, developmental coordination disorder); occupational therapy evaluation may be necessary to distinguish motor coordination disorders from ADHD (see
         <a class="medical medical_review" href="/z/d/html/594.html" rel="external">
          "Developmental coordination disorder: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Emotional and behavioral disorders
         </strong>
         – Emotional and behavioral disorders that can mimic or co-occur with ADHD include anxiety disorder, mood disorders, oppositional defiant disorder, conduct disorder, obsessive-compulsive disorder, substance use disorder, posttraumatic stress disorder, and adjustment disorder. The use of a broadband behavior scale may be helpful in the assessment of these disorders. However, evaluation by a mental health professional generally is necessary for diagnosis. (See
         <a class="local">
          'Evaluation for coexisting disorders'
         </a>
         above and
         <a class="local">
          'Behavior rating scales'
         </a>
         above and
         <a class="local">
          'Indications for referral'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psychosocial and environmental factors
         </strong>
         – Environmental factors that can contribute to inattention, impulsivity, or hyperactivity include a stressful home environment, an inappropriate educational setting, less structure and fewer rules at home than at school, and high-frequency digital media use. Psychosocial factors that may contribute to caregiver-reports of inattention, impulsivity, or hyperactivity include increased caregiver stress or mental health problems (eg, depression) [
         <a href="#rid83">
          83
         </a>
         ]. (See
         <a class="local">
          'Diagnosis in adolescents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In contrast to ADHD, psychosocial and environmental factors generally affect behavior only in one setting (eg, at home but not at school, or at school but not at home). Caregiver-child temperament or "personality" mismatch and caregiver mental health conditions (particularly maternal depression) can contribute to caregiver report of ADHD-type symptoms in the home setting. However, caregivers of ADHD children with limited resources or support may also develop stress-related mental health conditions; in such circumstances, multiple respondent (eg, teacher, coach) reports help to confirm the diagnosis of ADHD.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adverse childhood experiences
         </strong>
         – Exposure to adverse childhood experiences (ACEs) such as physical or emotional abuse, chronic neglect, chronic family hardship or mental illness, or community violence can lead to a prolonged stress response ("toxic stress") that has been shown to disrupt early brain development and cause permanent changes in brain architecture and subsequent neurodevelopment [
         <a href="#rid108">
          108
         </a>
         ]. Children exposed to ACEs are at higher risk for developing ADHD as well as other psychopathology [
         <a href="#rid22">
          22,23
         </a>
         ]. A comprehensive psychosocial history including screening for ACEs can identify these risks and help tailor treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Medical conditions
         </strong>
         – Medical conditions that may have clinical features that mimic ADHD include hearing or visual impairment, lead poisoning, thyroid abnormalities, sleep disorders (eg, obstructive sleep apnea, restless leg/periodic limb movement disorder), tics, and medication effects (eg,
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         ) [
         <a href="#rid6">
          6,20,109
         </a>
         ]. Symptoms of these conditions fluctuate with the disease course or exposure to medication. In contrast, the symptoms in ADHD are persistent and pervasive.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h1">
          INDICATIONS FOR REFERRAL
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evaluation by a pediatric specialist (eg, a psychologist, psychiatrist, neurologist, educational specialist, or developmental-behavioral pediatrician) is indicated for children in whom the following diagnoses are of concern or complicate the diagnosis of ADHD [
         <a href="#rid2">
          2,41
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intellectual disability
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Developmental disorder (eg, speech or motor delay)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Learning disorder
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Visual or hearing impairment
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of abuse or exposure to one or more adverse childhood experiences
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe aggression
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizure disorder
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coexisting learning and/or emotional problems
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic illness that requires treatment with a medication that interferes with learning
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children who continue to have problems in functioning despite treatment (see
         <a class="medical medical_review" href="/z/d/html/623.html" rel="external">
          "Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Response to treatment'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2155755">
         <span class="h1">
          RESOURCES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The National Institute for Children's Healthcare Quality (NICHQ), in conjunction with North Carolina's Center for Child Health Improvement, and the American Academy of Pediatrics (AAP), developed a toolkit to assist primary care practitioners in the evaluation and management of children with ADHD. The first edition of the toolkit includes information for caregivers, copies of ADHD-specific questionnaires for parents/caregivers and teachers, and an initial primary care evaluation form. It can be downloaded without charge through the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nichq.org%2Fresource%2Fcaring-children-adhd-resource-toolkit-clinicians&amp;token=zdFETL7sY7KzqjhZf9oR42LowCTa16H4ROpKLhTFdh8YlI5LYkc%2BGXGbQNzXACOaOYk%2Bjg9k41lGDpmUKjbF4tT%2FU7XNDOWPmVdn3H3Rjig%3D&amp;TOPIC_ID=624" target="_blank">
          NICHQ
         </a>
         . The third edition of the toolkit, which also includes tools and resources for preschool children and adolescents, is available for purchase through the AAP.
        </p>
        <p>
         Resources for caregivers of children with ADHD are provided in the table  (
         <a class="graphic graphic_table graphicRef60584" href="/z/d/graphic/60584.html" rel="external">
          table 5
         </a>
         ).
        </p>
        <p>
         Information for teachers of children with ADHD is available through
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fchadd.org%2Ffor-educators%2Foverview%2F&amp;token=wlrA9DBxGiu35Ozgdcr%2FyBvHCxd0c83%2Fzx9WN9uHt8ZKojCFC2N66PXxTxfdv6T7CXNinzPhQ9Xpb3mv2CXOmA%3D%3D&amp;TOPIC_ID=624" target="_blank">
          Children and Adults with Attention-Deficit/Hyperactivity Disorder
         </a>
         .
        </p>
        <p class="headingAnchor" id="H3993116263">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117871.html" rel="external">
          "Society guideline links: Attention deficit hyperactivity disorder"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20768326">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/15361.html" rel="external">
          "Patient education: Attention deficit hyperactivity disorder (ADHD) in children (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/1210.html" rel="external">
          "Patient education: Symptoms and diagnosis of attention deficit hyperactivity disorder in children (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/1195.html" rel="external">
          "Patient education: Treatment of attention deficit hyperactivity disorder in children (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – Attention deficit hyperactivity disorder (ADHD) is a behavioral condition with persistent and pervasive core symptoms of inattention, hyperactivity, and impulsivity. The symptoms affect cognitive, academic, behavioral, emotional, and social functioning. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – Evaluation for ADHD should be initiated in children ≥4 years of age who have symptoms of inattention, hyperactivity, or impulsivity or who have complaints frequently associated with ADHD (eg, poor school performance, difficulty making and keeping friends, difficulty with team sports). (See
         <a class="local">
          'Indications and process'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Evaluation for ADHD requires comprehensive medical, developmental, educational, and psychosocial evaluation to confirm the presence, persistence, pervasiveness, and functional complications of core symptoms, exclude other causes of core symptoms  (
         <a class="graphic graphic_table graphicRef69771" href="/z/d/graphic/69771.html" rel="external">
          table 1
         </a>
         ), and identify coexisting emotional, behavioral, and medical disorders (eg, anxiety, mood disorders, learning disorder, sleep disorders). (See
         <a class="local">
          'Medical evaluation'
         </a>
         above and
         <a class="local">
          'Evaluation for coexisting disorders'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The evaluation for ADHD requires information about the child's behavior in more than one setting (eg, home and school or after-school program). ADHD-specific behavior scales  (
         <a class="graphic graphic_table graphicRef81675" href="/z/d/graphic/81675.html" rel="external">
          table 3
         </a>
         ) can be used to gather this information from the parents/caregivers and teacher(s). (See
         <a class="local">
          'Educational evaluation'
         </a>
         above and
         <a class="local">
          'Behavior rating scales'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ancillary evaluation
         </strong>
         – The evaluation for ADHD does not require blood lead levels, thyroid hormone levels, neuroimaging, electroencephalography, or psychological testing unless these tests are indicated by findings in the clinical evaluation or to narrow the differential diagnosis and plan the approach to management. (See
         <a class="local">
          'Ancillary evaluation for select patients'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic criteria
         </strong>
         – The diagnosis of ADHD requires that the child meet the criteria defined by the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition, Text Revision or the International Classification of Diseases  (
         <a class="graphic graphic_table graphicRef53723" href="/z/d/graphic/53723.html" rel="external">
          table 4
         </a>
         ). The response to stimulant medication cannot be used to confirm or refute the diagnosis. (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis for ADHD includes developmental variations, neurologic or developmental conditions, emotional and behavioral disorders, psychosocial or environmental factors, and certain medical problems  (
         <a class="graphic graphic_table graphicRef69771" href="/z/d/graphic/69771.html" rel="external">
          table 1
         </a>
         ). Most of these conditions may coexist with ADHD and require simultaneous treatment. Given the broad differential diagnosis of ADHD and frequency of coexisting conditions, reevaluation of children with ADHD is warranted whenever symptoms worsen or new symptoms emerge. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above and
         <a class="local">
          'Evaluation for coexisting disorders'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          American Psychiatric Association. Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, American Psychiatric Association, Washington, DC 2022. p.68.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 2019; 144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Applegate B, Lahey BB, Hart EL, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry 1997; 36:1211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lahey BB, Applegate B, McBurnett K, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 1994; 151:1673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sibley MH, Pelham WE, Molina BSG, et al. Diagnosing ADHD in adolescence. J Consult Clin Psychol 2012; 80:139.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Supplemental information. Available at https://pediatrics.aappublications.org/content/suppl/2019/09/18/peds.2019-2528.DCSupplemental (Accessed on October 09, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levin FR, Kleber HD. Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv Rev Psychiatry 1995; 2:246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nigg JT, Blaskey LG, Huang-Pollock CL, Rappley MD. Neuropsychological executive functions and DSM-IV ADHD subtypes. J Am Acad Child Adolesc Psychiatry 2002; 41:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiler MD, Bernstein JH, Bellinger DC, Waber DP. Processing speed in children with attention deficit/hyperactivity disorder, inattentive type. Child Neuropsychol 2000; 6:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carlson CL, Mann M. Sluggish cognitive tempo predicts a different pattern of impairment in the attention deficit hyperactivity disorder, predominantly inattentive type. J Clin Child Adolesc Psychol 2002; 31:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brogan E, Cragg L, Gilmore C, et al. Inattention in very preterm children: implications for screening and detection. Arch Dis Child 2014; 99:834.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holbrook JR, Cuffe SP, Cai B, et al. Persistence of Parent-Reported ADHD Symptoms From Childhood Through Adolescence in a Community Sample. J Atten Disord 2016; 20:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoza B. Peer functioning in children with ADHD. Ambul Pediatr 2007; 7:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor E, Döpfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry 2004; 13 Suppl 1:I7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry 2000; 39:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet 2016; 387:1240.
          </a>
         </li>
         <li class="breakAll">
          Kemper AR, Maslow GR, Hill S, et al. Attention deficit hyperactivity disorder: Diagnosis and treatment in children and adolescents. Comparative Effectiveness Review No. 203. AHRQ Publication No. 18-EHC005-EF. Agency for Healthcare Research and Quality, Rockville, MD, January 2018. Available at: https://effectivehealthcare.ahrq.gov/opics/adhd-update/systematic-review-2018 (Accessed on January 30, 2018).
         </li>
         <li class="breakAll">
          National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: Diagnosis and management. NICE guideline [NG87], March 2018. https://www.nice.org.uk/guidance/NG87 (Accessed on October 09, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sedky K, Bennett DS, Carvalho KS. Attention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: a meta-analysis. Sleep Med Rev 2014; 18:349.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sleator EK, Ullmann RK. Can the physician diagnose hyperactivity in the office? Pediatrics 1981; 67:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang N, Gao M, Yu J, et al. Understanding the association between adverse childhood experiences and subsequent attention deficit hyperactivity disorder: A systematic review and meta-analysis of observational studies. Brain Behav 2022; 12:e32748.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crouch E, Radcliff E, Bennett KJ, et al. Examining the Relationship Between Adverse Childhood Experiences and ADHD Diagnosis and Severity. Acad Pediatr 2021; 21:1388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2003; 42:1015.
          </a>
         </li>
         <li class="breakAll">
          Agency for Healthcare Research and Quality. Diagnosis of Attention-Deficit/Hyperactivity Disorder. Clinical Focus. Rockville, MD, October 1999. www.ahrq.gov/clinic/tp/adhddtp.htm (Accessed on October 25, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolraich ML, Lambert W, Doffing MA, et al. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol 2003; 28:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolraich ML, Bard DE, Neas B, et al. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic teacher rating scale in a community population. J Dev Behav Pediatr 2013; 34:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bard DE, Wolraich ML, Neas B, et al. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population. J Dev Behav Pediatr 2013; 34:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGoey KE, DuPaul GJ, Haley E, Shelton TL. Parent and teacher ratings of attention-deficit/hyperactivity disorder in preschool: the ADHD Rating Scale-IV Preschool Version. J Psychopathol Behav Assess 2007; 29:269.
          </a>
         </li>
         <li class="breakAll">
          DuPaul GJ,  Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-5 for children and adolescents. New York. Guilford Press 2016. Available at: https://www.guilford.com/books/ADHD-Rating-Scale-5-for-Children-and-Adolescents/DuPaul-Power-Anastopoulos-Reid/9781462524877 (Accessed on October 02, 2019).
         </li>
         <li class="breakAll">
          American Psychiatric Association. Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, American Psychiatric Association, Arlington, VA 2013. p.59.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dreyer BP. The diagnosis and management of attention-deficit/hyperactivity disorder in preschool children: the state of our knowledge and practice. Curr Probl Pediatr Adolesc Health Care 2006; 36:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan A, Adesman A. Clinical diagnosis and management of attention deficit hyperactivity disorder in preschool children. Curr Opin Pediatr 2011; 23:684.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biederman J, Monuteaux MC, Kendrick E, et al. The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD. Arch Dis Child 2005; 90:1010.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koolwijk I, Stein DS, Chan E, et al. "Complex" attention-deficit hyperactivity disorder, more norm than exception? Diagnoses and comorbidities in a developmental clinic. J Dev Behav Pediatr 2014; 35:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tung I, Li JJ, Meza JI, et al. Patterns of Comorbidity Among Girls With ADHD: A Meta-analysis. Pediatrics 2016; 138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001; 40:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56:1073.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy F, Hay DA, Bennett KS, McStephen M. Gender differences in ADHD subtype comorbidity. J Am Acad Child Adolesc Psychiatry 2005; 44:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elia J, Ambrosini P, Berrettini W. ADHD characteristics: I. Concurrent co-morbidity patterns in children &amp; adolescents. Child Adolesc Psychiatry Ment Health 2008; 2:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbaresi WJ, Campbell L, Diekroger EA, et al. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr 2020; 41 Suppl 2S:S35.
          </a>
         </li>
         <li class="breakAll">
          American Psychiatric Association. Oppositional defiant disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, American Psychiatric Association, Washington, DC 2022. p.522.
         </li>
         <li class="breakAll">
          American Psychiatric Association. Conduct Disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, American Psychiatric Association, Washington, DC 2022. p.530.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zametkin AJ, Ernst M. Problems in the management of attention-deficit-hyperactivity disorder. N Engl J Med 1999; 340:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn CA, Kelly PC, Walker WO Jr. Lead screening in children with attention deficit hyperactivity disorder and developmental delay. Clin Pediatr (Phila) 1995; 34:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gittelman R, Eskenazi B. Lead and hyperactivity revisited. An investigation of nondisadvantaged children. Arch Gen Psychiatry 1983; 40:827.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zader SJ, Williams E, Buryk MA. Mental Health Conditions and Hyperthyroidism. Pediatrics 2019; 144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stephen E, Kindley AD. Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities? Arch Dis Child 2006; 91:860.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bastain TM, Lewczyk CM, Sharp WS, et al. Cytogenetic abnormalities in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2002; 41:806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doyle AE, Biederman J, Seidman LJ, et al. Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit-hyperactivity disorder. J Consult Clin Psychol 2000; 68:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bélanger SA, Andrews D, Gray C, Korczak D. ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity. Paediatr Child Health 2018; 23:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aman CJ, Roberts RJ Jr, Pennington BF. A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder: frontal lobe versus right parietal lobe theories. Dev Psychol 1998; 34:956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubia K, Taylor E, Smith AB, et al. Neuropsychological analyses of impulsiveness in childhood hyperactivity. Br J Psychiatry 2001; 179:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hale JB, Hoeppner JA, DeWitt MB, et al. Evaluating medication response in ADHD: cognitive, behavioral, and single-subject methodology. J Learn Disabil 1998; 31:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kempton S, Vance A, Maruff P, et al. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med 1999; 29:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Risser MG, Bowers TG. Cognitive and neuropsychological characteristics of attention deficit hyperactivity disorder children receiving stimulant medications. Percept Mot Skills 1993; 77:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 1995; 34:886.
          </a>
         </li>
         <li class="breakAll">
          Krull KR, George MR, Strother D. Quantitative electroencephalography and neurofeedback. In: Pediatric Neuropsychological Intervention: A Critical Review of Science &amp; Practice, Hunter SJ, Donders J (Eds), Cambridge University Press, Cambridge 2007. p.392.
         </li>
         <li class="breakAll">
          US Food and Drug Administration. FDA permits marketing of first brain wave test to help assess children and teens for ADHD. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm360811.htm (Accessed on July 16, 2013).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lazzaro I, Gordon E, Li W, et al. Simultaneous EEG and EDA measures in adolescent attention deficit hyperactivity disorder. Int J Psychophysiol 1999; 34:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lazzaro I, Gordon E, Whitmont S, et al. Quantified EEG activity in adolescent attention deficit hyperactivity disorder. Clin Electroencephalogr 1998; 29:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chabot RJ, Merkin H, Wood LM, et al. Sensitivity and specificity of QEEG in children with attention deficit or specific developmental learning disorders. Clin Electroencephalogr 1996; 27:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snyder SM, Hall JR. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol 2006; 23:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swartwood JN, Swartwood MO, Lubar JF, Timmermann DL. EEG differences in ADHD-combined type during baseline and cognitive tasks. Pediatr Neurol 2003; 28:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuperman S, Johnson B, Arndt S, et al. Quantitative EEG differences in a nonclinical sample of children with ADHD and undifferentiated ADD. J Am Acad Child Adolesc Psychiatry 1996; 35:1009.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barry RJ, Clarke AR, Johnstone SJ. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin Neurophysiol 2003; 114:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dupuy FE, Barry RJ, Clarke AR, et al. Sex differences between the combined and inattentive types of attention-deficit/hyperactivity disorder: an EEG perspective. Int J Psychophysiol 2013; 89:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arns M, Conners CK, Kraemer HC. A decade of EEG Theta/Beta Ratio Research in ADHD: a meta-analysis. J Atten Disord 2013; 17:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gloss D, Varma JK, Pringsheim T, Nuwer MR. Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2016; 87:2375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998; 279:1100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Power TJ, Costigan TE, Leff SS, et al. Assessing ADHD across settings: contributions of behavioral assessment to categorical decision making. J Clin Child Psychol 2001; 30:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rapoport JL, Buchsbaum MS, Zahn TP, et al. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science 1978; 199:560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peloquin LJ, Klorman R. Effects of methylphenidate on normal children's mood, event-related potentials, and performance in memory scanning and vigilance. J Abnorm Psychol 1986; 95:88.
          </a>
         </li>
         <li class="breakAll">
          6A05 Attention deficit hyperactivity disorder. ICD-11 for Mortality and Morbidity Statistics. (Version 02/2022). https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f821852937 (Accessed on April 21, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lahey BB, Pelham WE, Loney J, et al. Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry 2005; 62:896.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larsson H, Dilshad R, Lichtenstein P, Barker ED. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry 2011; 52:954.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hinshaw SP, Owens EB, Zalecki C, et al. Prospective follow-up of girls with attention-deficit/hyperactivity disorder into early adulthood: continuing impairment includes elevated risk for suicide attempts and self-injury. J Consult Clin Psychol 2012; 80:1041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lahey BB, Pelham WE, Loney J, et al. Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age. Am J Psychiatry 2004; 161:2014.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campbell SB, Ewing LJ, Breaux AM, Szumowski EK. Parent-referred problem three-year-olds: follow-up at school entry. J Child Psychol Psychiatry 1986; 27:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGee R, Partridge F, Williams S, Silva PA. A twelve-year follow-up of preschool hyperactive children. J Am Acad Child Adolesc Psychiatry 1991; 30:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riddle MA, Yershova K, Lazzaretto D, et al. The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry 2013; 52:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Law EC, Sideridis GD, Prock LA, Sheridan MA. Attention-deficit/hyperactivity disorder in young children: predictors of diagnostic stability. Pediatrics 2014; 133:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munzer TG, Miller AL, Brophy-Herb HE, et al. Characteristics Associated With Parent-Teacher Concordance on Child Behavior Problem Ratings in Low-Income Preschoolers. Acad Pediatr 2018; 18:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adler LA, Newcorn JH. Administering and evaluating the results of the adult ADHD Self-Report Scale (ASRS) in adolescents. J Clin Psychiatry 2011; 72:e20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith BH, Pelham WE, Gnagy E, et al. The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder. J Consult Clin Psychol 2000; 68:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sibley MH, Rohde LA, Swanson JM, et al. Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. Am J Psychiatry 2018; 175:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ra CK, Cho J, Stone MD, et al. Association of Digital Media Use With Subsequent Symptoms of Attention-Deficit/Hyperactivity Disorder Among Adolescents. JAMA 2018; 320:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radesky J. Digital Media and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adolescents. JAMA 2018; 320:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Novak SP, Kroutil LA, Williams RL, Van Brunt DL. The nonmedical use of prescription ADHD medications: results from a national Internet panel. Subst Abuse Treat Prev Policy 2007; 2:32.
          </a>
         </li>
         <li class="breakAll">
          Leslie LK, Guevara JP. Attention-deficit/hyperactivity disorder. In: American Academy of Pediatrics Textbook of Pediatric Care, McInerny TK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.1201.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morrow RL, Garland EJ, Wright JM, et al. Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ 2012; 184:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nomura K, Okada K, Noujima Y, et al. A clinical study of attention-deficit/hyperactivity disorder in preschool children--prevalence and differential diagnoses. Brain Dev 2014; 36:778.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilger JW, Pennington BF, DeFries JC. A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia. J Am Acad Child Adolesc Psychiatry 1992; 31:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brikell I, Kuja-Halkola R, Larsson JO, et al. Relative Immaturity in Childhood and Attention-Deficit/Hyperactivity Disorder Symptoms From Childhood to Early Adulthood: Exploring Genetic and Environmental Overlap Across Development. J Am Acad Child Adolesc Psychiatry 2016; 55:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen MH, Lan WH, Bai YM, et al. Influence of Relative Age on Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder in Taiwanese Children. J Pediatr 2016; 172:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Layton TJ, Barnett ML, Hicks TR, Jena AB. Attention Deficit-Hyperactivity Disorder and Month of School Enrollment. N Engl J Med 2018; 379:2122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caye A, Petresco S, de Barros AJD, et al. Relative Age and Attention-Deficit/Hyperactivity Disorder: Data From Three Epidemiological Cohorts and a Meta-analysis. J Am Acad Child Adolesc Psychiatry 2020; 59:990.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vuori M, Martikainen JE, Koski-Pirilä A, et al. Children's Relative Age and ADHD Medication Use: A Finnish Population-Based Study. Pediatrics 2020; 146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Root A, Brown JP, Forbes HJ, et al. Association of Relative Age in the School Year With Diagnosis of Intellectual Disability, Attention-Deficit/Hyperactivity Disorder, and Depression. JAMA Pediatr 2019; 173:1068.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wijburg FA, Węgrzyn G, Burton BK, Tylki-Szymańska A. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder. Acta Paediatr 2013; 102:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miodovnik A, Harstad E, Sideridis G, Huntington N. Timing of the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. Pediatrics 2015; 136:e830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nigg JT, Swanson JM, Hinshaw SP. Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response and results for parents. Neuropsychologia 1997; 35:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Purvis KL, Tannock R. Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls. J Abnorm Child Psychol 1997; 25:133.
          </a>
         </li>
         <li class="breakAll">
          Wechsler D. Wechsler Intelligence Scale for Children: 5th Edition. Pearson, Bloomington, MN 2014.
         </li>
         <li class="breakAll">
          Elliott C. Differential Ability Scales-II. The Psychological Corporation, San Antonio, TX 2007.
         </li>
         <li class="breakAll">
          Wechsler Individual Achievement Test-Fourth Edition. Pearson, Bloomington, MN 2020.
         </li>
         <li class="breakAll">
          Wilkinson GS, Robertson GJ. Wide Range Achievement Test – 5. Pearson, Bloomington, MN 2017.
         </li>
         <li class="breakAll">
          Toxic stress. Harvard University Center on Developing Children. Available at: https://developingchild.harvard.edu/science/key-concepts/toxic-stress/ (Accessed on February 01, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pearl PL, Weiss RE, Stein MA. Medical mimics. Medical and neurological conditions simulating ADHD. Ann N Y Acad Sci 2001; 931:97.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 624 Version 50.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : American Psychiatric Association. Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, American Psychiatric Association, Washington, DC 2022. p.68.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31570648" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9291722" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7943460" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22148878" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Diagnosing ADHD in adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22148878" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Diagnosing ADHD in adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9384909" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11800208" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Neuropsychological executive functions and DSM-IV ADHD subtypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11402399" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Processing speed in children with attention deficit/hyperactivity disorder, inattentive type.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11845644" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Sluggish cognitive tempo predicts a different pattern of impairment in the attention deficit hyperactivity disorder, predominantly inattentive type.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24842798" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Inattention in very preterm children: implications for screening and detection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24994874" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Persistence of Parent-Reported ADHD Symptoms From Childhood Through Adolescence in a Community Sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17261489" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Peer functioning in children with ADHD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15322953" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : European clinical guidelines for hyperkinetic disorder -- first upgrade.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17581453" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10673829" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26386541" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Attention deficit hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26386541" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Attention deficit hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26386541" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Attention deficit hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24581717" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Attention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7243422" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Can the physician diagnose hyperactivity in the office?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36068993" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Understanding the association between adverse childhood experiences and subsequent attention deficit hyperactivity disorder: A systematic review and meta-analysis of observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33746042" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Examining the Relationship Between Adverse Childhood Experiences and ADHD Diagnosis and Severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12960702" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12960702" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14602846" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23363973" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic teacher rating scale in a community population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23363972" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Parent and teacher ratings of attention-deficit/hyperactivity disorder in preschool: the ADHD Rating Scale-IV Preschool Version
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Parent and teacher ratings of attention-deficit/hyperactivity disorder in preschool: the ADHD Rating Scale-IV Preschool Version
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Parent and teacher ratings of attention-deficit/hyperactivity disorder in preschool: the ADHD Rating Scale-IV Preschool Version
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16360075" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The diagnosis and management of attention-deficit/hyperactivity disorder in preschool children: the state of our knowledge and practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22045309" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Clinical diagnosis and management of attention deficit hyperactivity disorder in preschool children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16177156" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25343695" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : "Complex" attention-deficit hyperactivity disorder, more norm than exception? Diagnoses and comorbidities in a developmental clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27694280" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Patterns of Comorbidity Among Girls With ADHD: A Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11211363" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10591283" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15782084" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Gender differences in ADHD subtype comorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18598351" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : ADHD characteristics: I. Concurrent co-morbidity patterns in children&amp;adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31996577" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31996577" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31996577" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9878644" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Problems in the management of attention-deficit-hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7586924" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Lead screening in children with attention deficit hyperactivity disorder and developmental delay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6683492" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Lead and hyperactivity revisited. An investigation of nondisadvantaged children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31582535" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Mental Health Conditions and Hyperthyroidism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16990360" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12108805" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Cytogenetic abnormalities in attention-deficit/hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10883564" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit-hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30681669" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9779742" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder: frontal lobe versus right parietal lobe theories.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11483475" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Neuropsychological analyses of impulsiveness in childhood hyperactivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9813958" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Evaluating medication response in ADHD: cognitive, behavioral, and single-subject methodology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10405075" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8284137" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Cognitive and neuropsychological characteristics of attention deficit hyperactivity disorder children receiving stimulant medications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7649959" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7649959" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7649959" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10576397" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Simultaneous EEG and EDA measures in adolescent attention deficit hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9472424" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Quantified EEG activity in adolescent attention deficit hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8719499" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Sensitivity and specificity of QEEG in children with attention deficit or specific developmental learning disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17016156" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12770673" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : EEG differences in ADHD-combined type during baseline and cognitive tasks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8755797" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Quantitative EEG differences in a nonclinical sample of children with ADHD and undifferentiated ADD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12559224" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23603052" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Sex differences between the combined and inattentive types of attention-deficit/hyperactivity disorder: an EEG perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23086616" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : A decade of EEG Theta/Beta Ratio Research in ADHD: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27760867" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9546570" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11501256" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Assessing ADHD across settings: contributions of behavioral assessment to categorical decision making.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/341313" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3700853" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Effects of methylphenidate on normal children's mood, event-related potentials, and performance in memory scanning and vigilance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3700853" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Effects of methylphenidate on normal children's mood, event-related potentials, and performance in memory scanning and vigilance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16061767" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21434915" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22889337" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Prospective follow-up of girls with attention-deficit/hyperactivity disorder into early adulthood: continuing impairment includes elevated risk for suicide attempts and self-injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15514401" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3745347" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Parent-referred problem three-year-olds: follow-up at school entry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2016226" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : A twelve-year follow-up of preschool hyperactive children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23452683" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24639272" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Attention-deficit/hyperactivity disorder in young children: predictors of diagnostic stability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29081361" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Characteristics Associated With Parent-Teacher Concordance on Child Behavior Problem Ratings in Low-Income Preschoolers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21733473" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Administering and evaluating the results of the adult ADHD Self-Report Scale (ASRS) in adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10883565" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29050505" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30027248" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Association of Digital Media Use With Subsequent Symptoms of Attention-Deficit/Hyperactivity Disorder Among Adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30027231" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Digital Media and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17974020" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : The nonmedical use of prescription ADHD medications: results from a national Internet panel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17974020" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : The nonmedical use of prescription ADHD medications: results from a national Internet panel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22392937" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24295540" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : A clinical study of attention-deficit/hyperactivity disorder in preschool children--prevalence and differential diagnoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1564037" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27663944" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Relative Immaturity in Childhood and Attention-Deficit/Hyperactivity Disorder Symptoms From Childhood to Early Adulthood: Exploring Genetic and Environmental Overlap Across Development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26973148" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Influence of Relative Age on Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder in Taiwanese Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30485780" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Attention Deficit-Hyperactivity Disorder and Month of School Enrollment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31442562" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Relative Age and Attention-Deficit/Hyperactivity Disorder: Data From Three Epidemiological Cohorts and a Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32958613" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Children's Relative Age and ADHD Medication Use: A Finnish Population-Based Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31545342" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Association of Relative Age in the School Year With Diagnosis of Intellectual Disability, Attention-Deficit/Hyperactivity Disorder, and Depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23336697" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26371198" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Timing of the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9025120" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response and results for parents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109030" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109030" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109030" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109030" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109030" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109030" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11462759" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Medical mimics. Medical and neurological conditions simulating ADHD.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
